WILDER, Ky. – Quipt Home Medical shareholder Forager Capital Management (FCM) has submitted an updated, immediately actionable proposal to acquire all outstanding common shares of the company for $3.10 per share in cash, according to a recent Securities and Exchange Commission (SEC) filing.
FCM notes that the all-cash offer represents a substantial premium compared to Quipt’s recent trading levels—a 120% premium over the unaffected closing price of $1.41 on May 19, 2025, the final trading day before FCM’s initial letter of intent was made public on May 17, 2025.
Key Terms of the Proposal:
- Funding: The transaction will be financed entirely by an FCM affiliate using cash on hand, with no need for financing from Quipt or its shareholders.
- Due Diligence: No due diligence conditions apply, as FCM has already completed its review.
- Go-Shop & Deal Protections:
- 30-day go-shop period following the signing of a definitive agreement
- Subsequent no-shop/non-solicitation period
- Matching rights for FCM on competing offers
- Break-up fee of 3.5% during the go-shop period, increasing to 5.5% during the no-shop period
While the proposal is non-binding to comply with Canadian securities regulations, FCM emphasized its readiness to enter into definitive documentation on the outlined terms.
“FCM remains fully committed to working with the board to deliver maximum value for all stakeholders,” the firm stated. “This transaction is a top priority, and our legal and financial advisors are prepared to move quickly, with the potential to close within 16 weeks.”
